Edwards Lifesciences Corporation Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31)
Edwards Lifesciences Corporation (EW) reported Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-02.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds · last filed 2014-05-02
- Edwards Lifesciences Corporation available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $0.00.
- Edwards Lifesciences Corporation available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $0.00.
- Edwards Lifesciences Corporation available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00.
- Edwards Lifesciences Corporation available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $0.00.
- Edwards Lifesciences Corporation available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Edwards Lifesciences Corporation available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for fiscal 2012 was $2.10M, a 41.67% decline from fiscal 2011.
- Edwards Lifesciences Corporation available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for fiscal 2011 was $3.60M.
| Period end | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-02 | $0.00 derived: sum of 2 quarters · filed 2014-05-02 | $0.00 derived: sum of 3 quarters · filed 2014-05-02 | $0.00 derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $0.00 derived: sum of 3 quarters · filed 2014-02-28 | $0.00 10-K · filed 2014-02-28 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | $0.00 derived: sum of 3 quarters · filed 2014-05-02 | $0.00 derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-02 | $0.00 derived: sum of 2 quarters · filed 2014-05-02 | $0.00 derived: sum of 3 quarters · filed 2014-05-02 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $2.10M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.10M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $2.10M 10-Q · filed 2013-08-06 | |||
| 2011-12-31 | $3.60M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |